Fertio, the international fertility care group behind European Sperm Bank, has acquired Cascade Cryobank, a Washington state-based sperm bank, marking its expansion into the U.S. market.
The acquisition brings together Fertio’s 20+ years of global expertise with Cascade’s Early Disclosure Program – which allows parents to access donor identity information immediately after birth rather than waiting until the donor-conceived child turns 18, as is standard practice at most sperm banks.
“Welcoming Cascade Cryobank into the Fertio family is an important milestone,” said Fertio CEO David T. Hansen. “Their donor offering and innovative approach aligns strongly with our vision of rethinking fertility. Together, we see great potential to help more families conceive with donor transparency.”
“Joining Fertio gives us access to world-class donor management technology and the opportunity to set new standards in the fertility industry,” said Cascade Cryobank founder Dr. John Carpenter.
Cascade Cryobank was founded in 2021 and will continue to operate under its own name. The deal reflects continued consolidation in the fertility services space – joining the CSG.BIO acquisition of Hanabusa IVF and Asian Egg Bank announced earlier this month as global reproductive health platforms expand their U.S. footprint through acquisitions. Financial terms were not disclosed.
